These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 34418537)

  • 1. Anti-rods/rings autoantibodies in a patient with pancreatic injury.
    Katayama S; Kubota T; Takahashi H; Shiwaku H
    Autoimmun Rev; 2022 Jan; 21(1):102922. PubMed ID: 34418537
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery.
    Calise SJ; Chan EKL
    Autoimmun Rev; 2020 Oct; 19(10):102643. PubMed ID: 32805424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy.
    Keppeke GD; Calise SJ; Chan EK; Andrade LE
    World J Gastroenterol; 2016 Feb; 22(6):1966-74. PubMed ID: 26877604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential capacity of therapeutic drugs to induce Rods/Rings structures in vitro and in vivo and generation of anti-Rods/Rings autoantibodies.
    Keppeke GD; Prado MS; Nunes E; Perazzio SF; Rodrigues SH; Ferraz ML; Chan EK; Andrade LE
    Clin Immunol; 2016 Dec; 173():149-156. PubMed ID: 27746381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Autoantibody to Rods and Rings with Hepatitis C Outcome and Viral Load.
    Dhaouadi T; Abdellatif J; Jallouli M; Mejdoubi M; Sfar I; Mouelhi L; Aouini S; Ben Abdallah T; Gorgi Y
    Viral Immunol; 2019 Jun; 32(5):214-220. PubMed ID: 31081724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection.
    Stinton LM; Myers RP; Coffin CS; Fritzler MJ
    BMC Gastroenterol; 2013 Mar; 13():50. PubMed ID: 23506439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct-acting antivirals: The role of prior treatment with interferon plus ribavirin.
    Alsius M; Ferri MJ; Buxó M; López C; Serra I; Queralt X; Acero D
    Gastroenterol Hepatol; 2019 Feb; 42(2):82-89. PubMed ID: 30446175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against "rods and rings"-related IMPDH2 in hepatitis C genotype 1 and DAA therapy in a "real life" cohort.
    Dammermann W; Polywka S; Dettmann I; Mindorf S; Komorowski L; Wehmeyer M; Schulze Zur Wiesch J; Stöcker W; Lüth S
    Med Microbiol Immunol; 2017 Oct; 206(5):379-382. PubMed ID: 28815296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis C.
    Covini G; Carcamo WC; Bredi E; von Mühlen CA; Colombo M; Chan EK
    Antivir Ther; 2012; 17(5):805-11. PubMed ID: 22293655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-α.
    Keppeke GD; Nunes E; Ferraz ML; Silva EA; Granato C; Chan EK; Andrade LE
    PLoS One; 2012; 7(9):e45392. PubMed ID: 23028980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.
    Keppeke GD; Satoh M; Ferraz ML; Chan EK; Andrade LE
    Immunol Res; 2014 Oct; 60(1):38-49. PubMed ID: 24845459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients.
    Carcamo WC; Ceribelli A; Calise SJ; Krueger C; Liu C; Daves M; Villalta D; Bizzaro N; Satoh M; Chan EK
    J Clin Immunol; 2013 Feb; 33(2):420-6. PubMed ID: 23100146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-rods and rings autoantibodies can occur in the hepatitis c-naïve population.
    Shaikh Y; Krantz A; El-Farra Y
    J Prev Med Hyg; 2013 Sep; 54(3):175-80. PubMed ID: 24783898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribavirin induces widespread accumulation of IMP dehydrogenase into rods/rings structures in multiple major mouse organs.
    Keppeke GD; Calise SJ; Chan EKL; Andrade LEC
    Antiviral Res; 2019 Feb; 162():130-135. PubMed ID: 30605724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against "rings and rods"-associated inosine-5'-monophosphate dehydrogenase 2 in viral hepatitis C.
    Probst C; Radzimski C; Blöcker IM; Teegen B; Bogdanos DP; Stöcker W; Komorowski L
    Clin Chim Acta; 2013 Mar; 418():91-6. PubMed ID: 23333419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term persistence of anti-rods and rings antibodies in patients with chronic hepatitis C after antiviral treatment.
    da Silva Sacerdote AB; Filgueira NA; de Barros Barreto S; Batista AD; Lopes EP
    Immunol Res; 2018 Oct; 66(5):605-610. PubMed ID: 30220012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of combination therapy with pegylated-interferon alfa-2a plus ribavirin in autoantibody-positive chronic hepatitis C patients].
    Li YX; Yang YJ; Yang M; Chen LY; Lu JJ; Ma YJ; Liu K; Lei XZ; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):345-7. PubMed ID: 24025134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients.
    Novembrino C; Aghemo A; Ferraris Fusarini C; Maiavacca R; Matinato C; Lunghi G; Torresani E; Ronchi M; Garlaschi MC; Ramondetta M; Colombo M
    J Viral Hepat; 2014 Dec; 21(12):944-9. PubMed ID: 25040504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-rods/rings: a human model of drug-induced autoantibody generation.
    Calise SJ; Keppeke GD; Andrade LE; Chan EK
    Front Immunol; 2015; 6():41. PubMed ID: 25699057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism.
    Carella C; Mazziotti G; Morisco F; Rotondi M; Cioffi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
    Eur J Endocrinol; 2002 Jun; 146(6):743-9. PubMed ID: 12039693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.